Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
ceo Processed

Boris Jordan & Curaleaf

5 shared events · Importance 3 · Last updated Jul 13, 2026

Importance
3
Shared Events
5
Actions
0
Sentiment
0
Live sentiment trends, interaction importance charts, and action volume tracking available on the Ergen Dashboard

Boris Jordan is the founder, Chairman, and Chief Executive Officer of Curaleaf. He is also the largest individual shareholder, holding a significant equity stake and controlling voting shares.

84
Business
Boris Jordan: Boris Jordan>>>, Chairman and CEO of Curaleaf>>>, views the reverse stock split as a crucial step in the company's long-term strategy to uplist to a major U.S. stock exchange, anticipating regulatory changes in the cannabis industry.
Curaleaf: Curaleaf>>> is implementing a reverse stock split to increase its share price, aiming to meet listing criteria for major U.S. stock exchanges and attract institutional investors. This move is expected to improve its market positioning and access to capital.
May 26, 2026 · 8 articles
84
Business
Boris Jordan: Boris Jordan, Chairman and CEO of Curaleaf, commented on the return to the CURLF trading symbol, emphasizing the company's focus on strengthening its capital markets profile and positioning for future opportunities.
Curaleaf: Curaleaf's shares resumed trading under its original OTCQX symbol CURLF after a temporary transition period following a reverse stock split, providing continuity for investors and potentially strengthening its capital markets profile.
Jul 06, 2026 · 6 articles
63
Business
Boris Jordan: As Chairman and CEO of Curaleaf, Boris Jordan publicly commented on the index inclusion, highlighting expected benefits of greater liquidity and investor attention.
Curaleaf: Curaleaf is the central entity of the event, gaining inclusion in the FTSE Global All-Cap Index, which is expected to boost liquidity, broaden its shareholder base, and raise institutional visibility.
Sep 23, 2026 · 7 articles
55
Business
Boris Jordan: As Chairman and CEO, Boris Jordan commented on the listing, highlighting its significance for Curaleaf's market maturity.
Curaleaf: Curaleaf is the subject of the event; the options listing enhances its market maturity and provides investors with new hedging and income strategies, potentially increasing liquidity and institutional interest.
Jul 10, 2026 · 6 articles
55
Regulatory
Boris Jordan: As CEO and Chairman of Curaleaf, Boris Jordan announced the registration milestone, highlighting the company's long-term investment in Spain and its commitment to providing standardized cannabis medicines.
Curaleaf: Curaleaf secured the first registration of standardized cannabis preparations in Spain under the new Royal Decree 903/2025, strengthening its leadership in the European medicinal cannabis market and potentially increasing its market share and revenue.
Jul 13, 2026 · 8 articles
ERGEN INTELLIGENCE
Explore this relationship live

Track how Boris Jordan and Curaleaf interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.